{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:06:49Z","timestamp":1794049609147,"version":"4.8.0"},"reference-count":183,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2 and 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disorder, characterized by progressive loss of cognition. Over 35 million individuals currently have AD worldwide. Unfortunately, current therapies are limited to very modest symptomatic relief. The brains of AD patients are characterized by the deposition of amyloid-\u03b2 and hyperphosphorylated forms of tau protein. AD brains also show neurodegeneration and high levels of oxidative stress and inflammation. The phytocannabinoid cannabidiol (CBD) possesses neuroprotective, antioxidant and anti-inflammatory properties and reduces amyloid-\u03b2 production and tau hyperphosphorylation <jats:italic toggle=\"yes\">in vitro<\/jats:italic>. CBD has also been shown to be effective <jats:italic toggle=\"yes\">in vivo<\/jats:italic> making the phytocannabinoid an interesting candidate for novel therapeutic interventions in AD, especially as it lacks psychoactive or cognition-impairing properties. CBD treatment would be in line with preventative, multimodal drug strategies targeting a combination of pathological symptoms, which might be ideal for AD therapy. Thus, this review will present a brief introduction to AD biology and current treatment options before outlining comprehensively CBD biology and pharmacology, followed by in-vitro and in-vivo evidence for the therapeutic potential of CBD. We will also discuss the role of the endocannabinioid system in AD before commenting on the potential future of CBD for AD therapy (including safety aspects).<\/jats:p>","DOI":"10.1097\/fbp.0000000000000247","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:00:53Z","timestamp":1470762053000},"page":"142-160","source":"Crossref","is-referenced-by-count":54,"title":["The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer\u2019s disease"],"prefix":"10.1097","volume":"28","author":[{"given":"Tim","family":"Karl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.92.2380.115","article-title":"Marihuana","volume":"92","author":"Adams","year":"1940","journal-title":"Science"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.euroneuro.2013.10.002","article-title":"In vivo type 1 cannabinoid receptor availability in Alzheimer\u2019s disease","volume":"24","author":"Ahmad","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J Neurochem"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/fn.2013.37702","article-title":"What causes Alzheimer\u2019s disease?","volume":"51","author":"Armstrong","year":"2013","journal-title":"Folia Neuropathol"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.2174\/138161212802884726","article-title":"The yin and yang of Cannabis-induced psychosis: the actions of \u0394(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia","volume":"18","author":"Arnold","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mcn.2013.06.004","article-title":"Role of the cannabinoid system in the transit of beta-amyloid across the blood\u2013brain barrier","volume":"56","author":"Bachmeier","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1523\/JNEUROSCI.0188-12.2012","article-title":"Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027","volume":"32","author":"Barten","year":"2012","journal-title":"J Neurosci"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1021\/bi802361k","article-title":"Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems","volume":"48","author":"Baruch-Suchodolsky","year":"2009","journal-title":"Biochemistry"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00439-010-0924-2","article-title":"Investigation of 15 of the top candidate genes for late-onset Alzheimer\u2019s disease","volume":"129","author":"Belbin","year":"2011","journal-title":"Hum Genet"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0892-0362(94)00053-G","article-title":"The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats","volume":"17","author":"Belue","year":"1995","journal-title":"Neurotoxicol Teratol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J Neurosci"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12035-007-8006-8","article-title":"The endocannabinoid system and Alzheimer\u2019s disease","volume":"36","author":"Benito","year":"2007","journal-title":"Mol Neurobiol"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J Cell Biol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/nbdi.2000.0313","article-title":"beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress","volume":"7","author":"Brera","year":"2000","journal-title":"Neurobiol Dis"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.3987-04.2004","article-title":"Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide","volume":"24","author":"Camacho","year":"2004","journal-title":"J Neurosci"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bjp.0707446","article-title":"Alzheimer\u2019s disease; taking the edge off with cannabinoids?","volume":"152","author":"Campbell","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R28-20230910","first-page":"81","article-title":"Hippocampal proliferative processes are needed for behavioral effects of cannabidiol","volume":"19","author":"Campos","year":"2011","journal-title":"Revista de Neurosciencias"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2005.03.006","article-title":"Dual role of nitric oxide in adult neurogenesis","volume":"50","author":"C\u00e1rdenas","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-130050","article-title":"Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy","volume":"35","author":"Casarejos","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/156720510791050948","article-title":"Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer\u2019s disease mouse model","volume":"7","author":"Chen","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014a","journal-title":"Psychopharmacology (Berl)"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"2014b","journal-title":"J Alzheimers Dis"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 3","key":"R37-20230910","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1042\/BJ20050560","article-title":"Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death","volume":"391","author":"D\u2019Abramo","year":"2005","journal-title":"Biochem J"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(00)00021-7","article-title":"Wnt signaling function in Alzheimer\u2019s disease","volume":"33","author":"De Ferrari","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"R39-20230910","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2982.2008.01114.x","article-title":"Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase","volume":"20","author":"De Filippis","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1460-9568.2005.04083.x","article-title":"Recognition memory impairment and brain oxidative stress induced by postnatal iron administration","volume":"21","author":"De Lima","year":"2005","journal-title":"Eur J Neurosci"},{"key":"R41-20230910","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u03949-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R42-20230910","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"R44-20230910","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/jmri.21730","article-title":"Correlation of iron in the hippocampus with MMSE in patients with Alzheimer\u2019s disease","volume":"29","author":"Ding","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"R45-20230910","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R46-20230910","doi-asserted-by":"crossref","first-page":"e39186","DOI":"10.1371\/journal.pone.0039186","article-title":"Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease","volume":"7","author":"D\u2019Addario","year":"2012","journal-title":"PLoS One"},{"key":"R47-20230910","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0074-7742(06)78010-2","article-title":"Cannabinoids and psychosis","volume":"78","author":"D\u2019Souza","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J Neuroinflammation"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006a","journal-title":"J Mol Med"},{"key":"R50-20230910","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006b","journal-title":"Neurosci Lett"},{"key":"R51-20230910","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R52-20230910","doi-asserted-by":"crossref","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"R53-20230910","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/mp060066m","article-title":"A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol Pharm"},{"key":"R54-20230910","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuropharm.2004.08.009","article-title":"Differential effects of THC- or CBD-rich Cannabis extracts on working memory in rats","volume":"47","author":"Fadda","year":"2004","journal-title":"Neuropharmacology"},{"key":"R55-20230910","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R56-20230910","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1046\/j.1432-1327.2001.02030.x","article-title":"Biosynthesis of cannabinoids. Incorporation experiments with (13)C-labeled glucoses","volume":"268","author":"Fellermeier","year":"2001","journal-title":"Eur J Biochem"},{"key":"R57-20230910","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"R58-20230910","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1096\/fj.02-0327fje","article-title":"Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway","volume":"16","author":"Garrido","year":"2002","journal-title":"FASEB J"},{"key":"R59-20230910","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides-GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R60-20230910","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrn2420","article-title":"Animal models of Alzheimer\u2019s disease and frontotemporal dementia","volume":"9","author":"G\u00f6tz","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"R61-20230910","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"G\u00f6tz","year":"2001","journal-title":"Science"},{"key":"R62-20230910","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2008-14410","article-title":"Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods?","volume":"14","author":"G\u00f6tz","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"R63-20230910","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R64-20230910","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/cbdv.200790151","article-title":"The toxicology of Cannabis and Cannabis prohibition","volume":"4","author":"Grotenhermen","year":"2007","journal-title":"Chem Biodivers"},{"key":"R65-20230910","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1471-4159.1995.65010292.x","article-title":"Apoptotic cell death induced by beta-amyloid 1\u201342 peptide is cell type dependent","volume":"65","author":"Gschwind","year":"1995","journal-title":"J Neurochem"},{"key":"R66-20230910","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00095-2","article-title":"Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer\u2019s dementia and following stimulation with beta-amyloid 1-42 in vitro","volume":"322","author":"Haas","year":"2002","journal-title":"Neurosci Lett"},{"key":"R67-20230910","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R68-20230910","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R69-20230910","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0091-3057(91)90358-9","article-title":"Comparative metabolism of cannabidiol in dog, rat and man","volume":"40","author":"Harvey","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"R70-20230910","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuro.2011.12.015","article-title":"Contrasting protective effects of cannabinoids against oxidative stress and amyloid-\u03b2 evoked neurotoxicity in vitro","volume":"33","author":"Harvey","year":"2012","journal-title":"Neurotoxicology"},{"key":"R71-20230910","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000336872","article-title":"Off-target cannabinoid effects mediated by GPR55","volume":"89","author":"Henstridge","year":"2012","journal-title":"Pharmacology"},{"key":"R72-20230910","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat Med"},{"key":"R73-20230910","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1476-5381.2011.01364.x","article-title":"Endocannabinoid tone versus constitutive activity of cannabinoid receptors","volume":"163","author":"Howlett","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R74-20230910","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"R75-20230910","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J Neurochem"},{"key":"R76-20230910","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"R77-20230910","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"R78-20230910","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","article-title":"Cannabinoid effects on \u03b2 amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro","volume":"34","author":"Janefjord","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"R79-20230910","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R80-20230910","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1002\/j.1552-4604.2002.tb06004.x","article-title":"Cardiovascular system effects of marijuana","volume":"42","author":"Jones","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"R81-20230910","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.neurobiolaging.2011.03.012","article-title":"An amyloid \u03b242-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer\u2019s disease","volume":"33","author":"Jung","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R82-20230910","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2010.12.061","article-title":"Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe\/PS1\u0394E9 double transgenic mice","volume":"1376","author":"Kalifa","year":"2011","journal-title":"Brain Res"},{"issue":"Pt 4","key":"R83-20230910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer\u2019s disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"key":"R84-20230910","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/14728222.2012.671812","article-title":"The therapeutic potential of the endocannabinoid system for Alzheimer\u2019s disease","volume":"16","author":"Karl","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"R85-20230910","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9 \u2013 tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur J Pharmacol"},{"key":"R86-20230910","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R87-20230910","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1998.9981","article-title":"Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer\u2019s disease brains","volume":"254","author":"Kitamura","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R88-20230910","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates \u03949-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R89-20230910","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-511X-8-2","article-title":"Endocannabinoids in Alzheimer\u2019s disease and their impact on normative cognitive performance: a case\u2013control and cohort study","volume":"8","author":"Koppel","year":"2009","journal-title":"Lipids Health Dis"},{"key":"R90-20230910","article-title":"Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer\u2019s disease","volume":"2010","author":"Krause","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"R91-20230910","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbadis.2004.06.016","article-title":"Pathways of tau fibrillization","volume":"1739","author":"Kuret","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"R92-20230910","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J Med Chem"},{"key":"R93-20230910","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuint.2010.10.010","article-title":"Intact cannabinoid CB1 receptors in the Alzheimer\u2019s disease cortex","volume":"57","author":"Lee","year":"2010","journal-title":"Neurochem Int"},{"key":"R94-20230910","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","article-title":"Different effects of nabilone and cannabidiol on binocular depth inversion in Man","volume":"66","author":"Leweke","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"R95-20230910","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"R96-20230910","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02246292","article-title":"Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats","volume":"119","author":"Lichtman","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"R97-20230910","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nature04108","article-title":"Wnt signalling regulates adult hippocampal neurogenesis","volume":"437","author":"Lie","year":"2005","journal-title":"Nature"},{"key":"R98-20230910","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R99-20230910","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J Control Release"},{"key":"R100-20230910","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R101-20230910","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.093500","article-title":"A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo","volume":"316","author":"Lunn","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R102-20230910","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J Hepatol"},{"key":"R103-20230910","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R104-20230910","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.npp.1301376","article-title":"Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances \u2018liking\u2019 of a sweet reward","volume":"32","author":"Mahler","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R105-20230910","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat Neurosci"},{"key":"R106-20230910","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00008877-199605000-00008","article-title":"The endogenous cannabinoid receptor agonist anandamide impairs memory in rats","volume":"7","author":"Mallet","year":"1996","journal-title":"Behav Pharmacol"},{"key":"R107-20230910","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.biopha.2008.02.004","article-title":"Inflammation and aging: can endocannabinoids help?","volume":"62","author":"Marchalant","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"R108-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","article-title":"Alzheimer\u2019s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy","volume":"25","author":"Marchesi","year":"2011","journal-title":"FASEB J"},{"key":"R109-20230910","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nat Neurosci"},{"key":"R110-20230910","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol Pharmacol"},{"key":"R111-20230910","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R112-20230910","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/13550280290100978","article-title":"Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer\u2019s disease","volume":"8","author":"Mattson","year":"2002","journal-title":"J Neurovirol"},{"key":"R113-20230910","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2003.08.026","article-title":"Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade","volume":"477","author":"Mazzola","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R114-20230910","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/14728222.2014.988707","article-title":"Targeting microglia for the treatment of Alzheimer\u2019s disease","volume":"19","author":"McGeer","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"R115-20230910","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1476-5381.2012.02019.x","article-title":"GPR18 in microglia: implications for the CNS and endocannabinoid system signalling","volume":"167","author":"McHugh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R116-20230910","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci"},{"key":"R117-20230910","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R118-20230910","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","article-title":"A total synthesis of Dl-delta-1-tetrahydrocannabinol, the active constituent of hashish","volume":"87","author":"Mechoulam","year":"1965","journal-title":"J Am Chem Soc"},{"key":"R119-20230910","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"R120-20230910","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.phrs.2007.09.008","article-title":"Endocannabinoids and neurodegenerative diseases","volume":"56","author":"Micale","year":"2007","journal-title":"Pharmacol Res"},{"issue":"Pt 4","key":"R121-20230910","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer\u2019s disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"key":"R122-20230910","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"N\u00e4slund","year":"2000","journal-title":"JAMA"},{"key":"R123-20230910","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0968-0004(97)01085-2","article-title":"Caspases: killer proteases","volume":"22","author":"Nicholson","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"R124-20230910","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2007.07.019","article-title":"Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice","volume":"149","author":"Nilsson","year":"2007","journal-title":"Neuroscience"},{"key":"R125-20230910","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"R126-20230910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog Lipid Res"},{"key":"R127-20230910","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2174\/1389450110607011539","article-title":"The endocannabinoid system in ageing: a new target for drug development","volume":"7","author":"Paradisi","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R128-20230910","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer\u2019s disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox Res"},{"key":"R129-20230910","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.exger.2014.10.011","article-title":"Normal aging in rats and pathological aging in human Alzheimer\u2019s disease decrease FAAH activity: modulation by cannabinoid agonists","volume":"60","author":"Pascual","year":"2014","journal-title":"Exp Gerontol"},{"key":"R130-20230910","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/gps.1828","article-title":"The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation","volume":"23","author":"Passmore","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"R131-20230910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R133-20230910","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sci"},{"key":"R134-20230910","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R135-20230910","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)02624-9","article-title":"(\u2212)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens","volume":"456","author":"Pertwee","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R136-20230910","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"R137-20230910","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"R138-20230910","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"R139-20230910","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J Neurosci"},{"key":"R140-20230910","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential Cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R141-20230910","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"R142-20230910","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R143-20230910","first-page":"289","article-title":"Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors","volume":"20","author":"Satoh","year":"2000","journal-title":"Neuropathology"},{"key":"R144-20230910","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav Brain Res"},{"key":"R145-20230910","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00172-9","article-title":"Reduced binocular depth inversion in schizophrenic patients","volume":"53","author":"Schneider","year":"2002","journal-title":"Schizophr Res"},{"key":"R146-20230910","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/jnr.21713","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer\u2019s-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"86","author":"Scholtzova","year":"2008","journal-title":"J Neurosci Res"},{"key":"R147-20230910","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders","volume":"23","author":"Scuderi","year":"2009","journal-title":"Phytother Res"},{"key":"R148-20230910","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother Res"},{"key":"R149-20230910","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R150-20230910","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2050-6511-15-58","article-title":"A protocol for the delivery of cannabidiol (CBD) and combined CBD and 9-tetrahydrocannabinol (THC) by vaporisation","volume":"15","author":"Solowij","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"R151-20230910","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"R152-20230910","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(95)11902-9","article-title":"Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells","volume":"197","author":"Sperber","year":"1995","journal-title":"Neurosci Lett"},{"key":"R153-20230910","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"R154-20230910","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"R155-20230910","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R156-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.20093","article-title":"Microglia and Alzheimer\u2019s disease pathogenesis","volume":"77","author":"Streit","year":"2004","journal-title":"J Neurosci Res"},{"key":"R157-20230910","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.neurobiolaging.2013.05.027","article-title":"Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer\u2019s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition","volume":"34","author":"Stumm","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R158-20230910","first-page":"12","article-title":"Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy","volume":"1","author":"Takeuchi","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R159-20230910","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: an overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"key":"R160-20230910","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/cr.2010.3","article-title":"A GPCR\/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis","volume":"20","author":"Teng","year":"2010","journal-title":"Cell Res"},{"key":"R161-20230910","first-page":"285","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R162-20230910","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R163-20230910","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"1283","author":"Tol\u00f3n","year":"2009","journal-title":"Brain Res"},{"key":"R164-20230910","first-page":"1985","article-title":"Regulation of cholesterol efflux by amyloid beta secretion","volume":"88","author":"Umeda","year":"2010","journal-title":"J Neurosci Res"},{"key":"R165-20230910","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","article-title":"Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels","volume":"63","author":"Van der Stelt","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"R166-20230910","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00213-006-0356-9","article-title":"Interactions between THC and cannabidiol in mouse models of cannabinoid activity","volume":"186","author":"Varvel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R167-20230910","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int J Geriatr Psychiatry"},{"key":"R168-20230910","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1352458510367462","article-title":"Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis","volume":"16","author":"Wade","year":"2010","journal-title":"Mult Scler"},{"key":"R169-20230910","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R170-20230910","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J Neurosci"},{"key":"R171-20230910","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R172-20230910","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/JCP.0b013e31820e861c","article-title":"Randomized, controlled crossover trial of dronabinol, 2.5\u2009mg, for agitation in 2 patients with dementia","volume":"31","author":"Walther","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R173-20230910","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","article-title":"Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids","volume":"19","author":"Watanabe","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"R174-20230910","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","article-title":"Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains","volume":"63","author":"Westlake","year":"1994","journal-title":"Neuroscience"},{"key":"R175-20230910","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008877-199909000-00008","article-title":"Cannabinoid ligands and their effects on learning and performance in rhesus monkeys","volume":"10","author":"Winsauer","year":"1999","journal-title":"Behav Pharmacol"},{"key":"R176-20230910","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun Signal"},{"key":"R177-20230910","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1074\/jbc.R800013200","article-title":"Tau mutations in neurodegenerative diseases","volume":"284","author":"Wolfe","year":"2009","journal-title":"J Biol Chem"},{"key":"R178-20230910","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2012.06.011","article-title":"Activation of the CB2 receptor system reverses amyloid-induced memory deficiency","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R179-20230910","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0197-4580(01)00297-4","article-title":"Do NSAIDs prevent Alzheimer\u2019s disease? And, if so, why? The epidemiological evidence","volume":"22","author":"Zandi","year":"2001","journal-title":"Neurobiol Aging"},{"key":"R180-20230910","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14656566.3.4.365","article-title":"Is pharmacological prevention of Alzheimer\u2019s a realistic goal?","volume":"3","author":"Zandi","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R181-20230910","first-page":"141","article-title":"Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination","volume":"16","author":"Zuardi","year":"1983","journal-title":"Braz J Med Biol Res"},{"key":"R182-20230910","first-page":"137","article-title":"Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol","volume":"249","author":"Zuardi","year":"1981","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"R183-20230910","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"R184-20230910","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J Clin Psychiatry"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201704000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:11:59Z","timestamp":1694333519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201704000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":183,"journal-issue":{"issue":"2 and 3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000247","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}